BRONCHIECTASIS may silently increase risk of non-tuberculous mycobacteria infection, according to new genetic evidence.
Bronchiectasis Increases NTM Infection Risk
A bidirectional Mendelian randomization analysis using genome-wide association data demonstrated that bronchiectasis significantly increases the risk of non-tuberculous mycobacteria (NTM) infection. Across two independent datasets, the odds ratios were 1.42 and 1.32, both reaching statistical significance. These findings reinforce prior observational data but move further by supporting a potential causal relationship rather than simple association.
The analysis included over 1,100 bronchiectasis cases and more than 186,000 controls, strengthening the reliability of the genetic signal. By leveraging Mendelian randomization, investigators aimed to reduce confounding factors and reverse causation that often limit traditional observational studies.
Evidence of Bidirectional Risk Between Bronchiectasis and NTM
Importantly, the study also evaluated the reverse relationship. NTM infection was associated with a modest but statistically significant increase in bronchiectasis risk in one dataset, with an odds ratio of 1.06. Although a second dataset did not replicate this finding independently, pooled meta-analysis demonstrated a consistent overall association, with an odds ratio of 1.05.
This bidirectional signal suggests that bronchiectasis and NTM infection may reinforce each other through overlapping pathological mechanisms. While the exact biological pathways were not explored in this analysis, the findings align with clinical observations of recurrent infection and structural lung damage.
Clinical Implications for Bronchiectasis Management
These results highlight the importance of vigilant monitoring for NTM infection in patients with bronchiectasis. Early identification and management may help mitigate disease progression and reduce respiratory morbidity compounding.
Conversely, clinicians managing NTM infection should remain aware of the potential for developing or worsening bronchiectasis. The findings underscore the need for integrated clinical strategies that address both conditions concurrently, particularly in high-risk populations.
Overall, this study strengthens the evidence base supporting a causal and clinically meaningful relationship between bronchiectasis and NTM, with implications for screening, diagnosis, and long-term disease management.
Reference
Gu J et al. The causal relationship between bronchiectasis and non-tuberculous mycobacteria infections: A bidirectional Mendelian randomization study and meta-analysis. Respir Investig. 2026;64(2):101387.
Featured Image: kelvn on Adobe Stock.
